

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.42921166 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.58403565 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.58403565 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.24231299 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.24231299 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.81420431 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.51881135 |
| 8 | oxidative demethylation (GO:0070989) | 6.20797233 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.13858477 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.13858477 |
| 11 | tryptophan catabolic process (GO:0006569) | 6.13858477 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.02413460 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.92476749 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.79035043 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.71825596 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.67742387 |
| 17 | phenylpropanoid metabolic process (GO:0009698) | 5.65555693 |
| 18 | urea cycle (GO:0000050) | 5.62748384 |
| 19 | urea metabolic process (GO:0019627) | 5.62748384 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.58642668 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.55085915 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.39523446 |
| 23 | cysteine metabolic process (GO:0006534) | 5.37351369 |
| 24 | ethanol metabolic process (GO:0006067) | 5.36380492 |
| 25 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.36206586 |
| 26 | protein carboxylation (GO:0018214) | 5.36206586 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.31573193 |
| 28 | complement activation, alternative pathway (GO:0006957) | 5.22680686 |
| 29 | regulation of plasminogen activation (GO:0010755) | 5.20214081 |
| 30 | regulation of protein activation cascade (GO:2000257) | 5.19209397 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 5.17369838 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 5.12969078 |
| 33 | bile acid metabolic process (GO:0008206) | 5.12580024 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.98631244 |
| 35 | aromatic amino acid family metabolic process (GO:0009072) | 4.96719151 |
| 36 | negative regulation of protein activation cascade (GO:2000258) | 4.95002857 |
| 37 | reverse cholesterol transport (GO:0043691) | 4.92299994 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.87519865 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.84569871 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 4.84569871 |
| 41 | macromolecular complex remodeling (GO:0034367) | 4.84569871 |
| 42 | regulation of complement activation (GO:0030449) | 4.84471652 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82688619 |
| 44 | negative regulation of blood coagulation (GO:0030195) | 4.81129296 |
| 45 | negative regulation of hemostasis (GO:1900047) | 4.81129296 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.81096522 |
| 47 | regulation of humoral immune response (GO:0002920) | 4.80534982 |
| 48 | homocysteine metabolic process (GO:0050667) | 4.77350433 |
| 49 | negative regulation of sterol transport (GO:0032372) | 4.76585510 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 4.76585510 |
| 51 | phospholipid efflux (GO:0033700) | 4.67429348 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.66848865 |
| 53 | acylglycerol homeostasis (GO:0055090) | 4.66848865 |
| 54 | acute-phase response (GO:0006953) | 4.66653470 |
| 55 | alpha-amino acid catabolic process (GO:1901606) | 4.64040265 |
| 56 | amino-acid betaine metabolic process (GO:0006577) | 4.60931987 |
| 57 | lysine metabolic process (GO:0006553) | 4.56322777 |
| 58 | lysine catabolic process (GO:0006554) | 4.56322777 |
| 59 | S-adenosylmethionine metabolic process (GO:0046500) | 4.54650721 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.51779919 |
| 61 | cellular glucuronidation (GO:0052695) | 4.48536665 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.44480556 |
| 63 | opsonization (GO:0008228) | 4.44068487 |
| 64 | glycine metabolic process (GO:0006544) | 4.43205093 |
| 65 | alkaloid metabolic process (GO:0009820) | 4.42226458 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 4.40737637 |
| 67 | negative regulation of wound healing (GO:0061045) | 4.38114724 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.37707535 |
| 69 | negative regulation of coagulation (GO:0050819) | 4.37251046 |
| 70 | drug catabolic process (GO:0042737) | 4.36237696 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 4.35424931 |
| 72 | coenzyme catabolic process (GO:0009109) | 4.34138463 |
| 73 | cholesterol efflux (GO:0033344) | 4.33593404 |
| 74 | cellular amino acid catabolic process (GO:0009063) | 4.26141501 |
| 75 | amine catabolic process (GO:0009310) | 4.25418193 |
| 76 | cellular biogenic amine catabolic process (GO:0042402) | 4.25418193 |
| 77 | negative regulation of complement activation (GO:0045916) | 4.23575843 |
| 78 | glutamate metabolic process (GO:0006536) | 4.21882483 |
| 79 | cytolysis (GO:0019835) | 4.20231721 |
| 80 | serine family amino acid metabolic process (GO:0009069) | 4.17587958 |
| 81 | benzene-containing compound metabolic process (GO:0042537) | 4.16374610 |
| 82 | low-density lipoprotein particle remodeling (GO:0034374) | 4.11732420 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 4.09649073 |
| 84 | positive regulation of hemostasis (GO:1900048) | 4.09649073 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 4.05383104 |
| 86 | ethanol oxidation (GO:0006069) | 4.02498920 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 4.02477350 |
| 88 | arginine metabolic process (GO:0006525) | 4.00577616 |
| 89 | cellular modified amino acid catabolic process (GO:0042219) | 4.00005917 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.99287406 |
| 91 | uronic acid metabolic process (GO:0006063) | 3.98484609 |
| 92 | glucuronate metabolic process (GO:0019585) | 3.98484609 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.96009139 |
| 94 | fibrinolysis (GO:0042730) | 3.94705698 |
| 95 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.92650922 |
| 96 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.92650922 |
| 97 | epoxygenase P450 pathway (GO:0019373) | 3.91519015 |
| 98 | ketone body metabolic process (GO:1902224) | 3.90976341 |
| 99 | regulation of bile acid biosynthetic process (GO:0070857) | 3.86791197 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.86643573 |
| 101 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.86514083 |
| 102 | exogenous drug catabolic process (GO:0042738) | 3.85265720 |
| 103 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.85046446 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.85046446 |
| 105 | blood coagulation, intrinsic pathway (GO:0007597) | 3.81652567 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.80585756 |
| 107 | negative regulation of lipase activity (GO:0060192) | 3.79786147 |
| 108 | positive regulation of lipid catabolic process (GO:0050996) | 3.79556522 |
| 109 | flavonoid metabolic process (GO:0009812) | 3.78081490 |
| 110 | positive regulation of coagulation (GO:0050820) | 3.77291856 |
| 111 | cofactor catabolic process (GO:0051187) | 3.76144272 |
| 112 | heme transport (GO:0015886) | 3.74946383 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.74148858 |
| 114 | organic acid catabolic process (GO:0016054) | 3.74148858 |
| 115 | sterol homeostasis (GO:0055092) | 3.74140970 |
| 116 | phospholipid homeostasis (GO:0055091) | 3.73567928 |
| 117 | complement activation, classical pathway (GO:0006958) | 3.71672809 |
| 118 | drug metabolic process (GO:0017144) | 3.69381078 |
| 119 | complement activation (GO:0006956) | 3.68137647 |
| 120 | plasma lipoprotein particle organization (GO:0071827) | 3.67777696 |
| 121 | protein activation cascade (GO:0072376) | 3.67096499 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.65631951 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.63028180 |
| 124 | short-chain fatty acid metabolic process (GO:0046459) | 3.62783199 |
| 125 | xenobiotic metabolic process (GO:0006805) | 3.58923492 |
| 126 | acute inflammatory response (GO:0002526) | 3.57624862 |
| 127 | response to mercury ion (GO:0046689) | 3.46681281 |
| 128 | regulation of lipoprotein particle clearance (GO:0010984) | 3.46043812 |
| 129 | regulation of acute inflammatory response (GO:0002673) | 3.40572735 |
| 130 | intestinal cholesterol absorption (GO:0030299) | 3.37622599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.41814606 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22782011 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07176379 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.50919489 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.31337818 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.09661765 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.81073200 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00501402 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99344844 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.06108797 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9317553 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99124731 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92648421 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.59887766 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59345419 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51924040 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41462965 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39881449 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33911326 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.24935170 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23617768 |
| 22 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21694834 |
| 23 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.21025260 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09751108 |
| 25 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07376267 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06359114 |
| 27 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01392735 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.98455413 |
| 29 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.97694202 |
| 30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96539069 |
| 31 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.96537092 |
| 32 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.92860849 |
| 33 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.92484240 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90863130 |
| 35 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89042569 |
| 36 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86186114 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85603504 |
| 38 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84226073 |
| 39 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83756748 |
| 40 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83489857 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83027760 |
| 42 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82828511 |
| 43 | NFYA_21822215_ChIP-Seq_K562_Human | 0.79813940 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.78818165 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78103432 |
| 46 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.76023678 |
| 47 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75690595 |
| 48 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.75647476 |
| 49 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.75400134 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74622491 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.74468193 |
| 52 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73743575 |
| 53 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.72605455 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70708192 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69442876 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.69351555 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.68750572 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.67712314 |
| 59 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.67596276 |
| 60 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.67561432 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.65375610 |
| 62 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.65202734 |
| 63 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.64757822 |
| 64 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.64554897 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.64470832 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63955316 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63955316 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63897925 |
| 69 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.63038471 |
| 70 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.62212827 |
| 71 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.61947916 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61217992 |
| 73 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60937577 |
| 74 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.60887504 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.58840283 |
| 76 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58064064 |
| 77 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.57917416 |
| 78 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.57025137 |
| 79 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.56808648 |
| 80 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56272145 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.56270144 |
| 82 | NFYB_21822215_ChIP-Seq_K562_Human | 0.55044406 |
| 83 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.54379006 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54242779 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.53790085 |
| 86 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.53429510 |
| 87 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.53414778 |
| 88 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.53342378 |
| 89 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.53341237 |
| 90 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.53010877 |
| 91 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52989563 |
| 92 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.52856557 |
| 93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52703612 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51736137 |
| 95 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.51707491 |
| 96 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.51635490 |
| 97 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.51373005 |
| 98 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51294886 |
| 99 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.50836797 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.50441650 |
| 101 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.50377135 |
| 102 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50330933 |
| 103 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50232315 |
| 104 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.50112779 |
| 105 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.49357876 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48981895 |
| 107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.48589482 |
| 108 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.47726280 |
| 109 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.47654228 |
| 110 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.47053362 |
| 111 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46871616 |
| 112 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46698945 |
| 113 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46343447 |
| 114 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45377275 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44981504 |
| 116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43132251 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42848971 |
| 118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.41867571 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.41415579 |
| 120 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41373091 |
| 121 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.41116191 |
| 122 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.41093276 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.41014297 |
| 124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40129679 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.39169737 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.38625352 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.38503011 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.37715076 |
| 129 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37609015 |
| 130 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.37338639 |
| 131 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37163930 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37074192 |
| 133 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.35786725 |
| 134 | * LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35723111 |
| 135 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35665927 |
| 136 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34950718 |
| 137 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34700491 |
| 138 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34123521 |
| 139 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.34110201 |
| 140 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.33443062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.40421030 |
| 2 | MP0005360_urolithiasis | 7.59893260 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.44908060 |
| 4 | MP0005365_abnormal_bile_salt | 6.10000654 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.43393120 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.27226002 |
| 7 | MP0003252_abnormal_bile_duct | 3.88596379 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.59954964 |
| 9 | MP0009840_abnormal_foam_cell | 3.37702959 |
| 10 | MP0005083_abnormal_biliary_tract | 3.00139313 |
| 11 | MP0003195_calcinosis | 2.92876760 |
| 12 | MP0005332_abnormal_amino_acid | 2.72601047 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.65502975 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.21241482 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.18481976 |
| 16 | MP0000609_abnormal_liver_physiology | 2.14448504 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.08493250 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.88043640 |
| 19 | MP0003868_abnormal_feces_composition | 1.84100962 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.82216554 |
| 21 | MP0001764_abnormal_homeostasis | 1.67916104 |
| 22 | MP0009697_abnormal_copulation | 1.61814703 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54433144 |
| 24 | MP0005451_abnormal_body_composition | 1.53772411 |
| 25 | MP0003011_delayed_dark_adaptation | 1.27744332 |
| 26 | MP0003186_abnormal_redox_activity | 1.26842171 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.24032076 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.21875235 |
| 29 | MP0000598_abnormal_liver_morphology | 1.15735030 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.13118514 |
| 31 | MP0005647_abnormal_sex_gland | 1.11432308 |
| 32 | MP0009764_decreased_sensitivity_to | 1.07566649 |
| 33 | MP0000604_amyloidosis | 1.04459208 |
| 34 | MP0005187_abnormal_penis_morphology | 1.02106185 |
| 35 | MP0002254_reproductive_system_inflammat | 1.02060245 |
| 36 | MP0009763_increased_sensitivity_to | 1.00133511 |
| 37 | MP0010368_abnormal_lymphatic_system | 0.93076565 |
| 38 | MP0005636_abnormal_mineral_homeostasis | 0.88948967 |
| 39 | MP0008469_abnormal_protein_level | 0.87189361 |
| 40 | MP0009642_abnormal_blood_homeostasis | 0.85829490 |
| 41 | MP0005408_hypopigmentation | 0.85391160 |
| 42 | MP0001915_intracranial_hemorrhage | 0.84896994 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 0.80632917 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 0.79185165 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.79110173 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.79097254 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.76073506 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 0.75291197 |
| 49 | MP0005670_abnormal_white_adipose | 0.74916430 |
| 50 | MP0002971_abnormal_brown_adipose | 0.70157114 |
| 51 | MP0003690_abnormal_glial_cell | 0.68695577 |
| 52 | MP0009053_abnormal_anal_canal | 0.68170453 |
| 53 | MP0002282_abnormal_trachea_morphology | 0.67648187 |
| 54 | MP0005334_abnormal_fat_pad | 0.67249454 |
| 55 | MP0004130_abnormal_muscle_cell | 0.67160186 |
| 56 | MP0005535_abnormal_body_temperature | 0.66969062 |
| 57 | MP0005266_abnormal_metabolism | 0.66008056 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.65453225 |
| 59 | MP0001661_extended_life_span | 0.65231810 |
| 60 | MP0003879_abnormal_hair_cell | 0.61773582 |
| 61 | MP0003329_amyloid_beta_deposits | 0.60620709 |
| 62 | MP0001756_abnormal_urination | 0.59353713 |
| 63 | MP0000639_abnormal_adrenal_gland | 0.58068012 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 0.55763545 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 0.55583929 |
| 66 | MP0005448_abnormal_energy_balance | 0.55065051 |
| 67 | MP0002249_abnormal_larynx_morphology | 0.54532004 |
| 68 | MP0003718_maternal_effect | 0.52433894 |
| 69 | MP0002822_catalepsy | 0.52418548 |
| 70 | MP0005395_other_phenotype | 0.49710597 |
| 71 | MP0005464_abnormal_platelet_physiology | 0.49286874 |
| 72 | MP0008874_decreased_physiological_sensi | 0.48999913 |
| 73 | MP0005023_abnormal_wound_healing | 0.48186593 |
| 74 | MP0008872_abnormal_physiological_respon | 0.47784691 |
| 75 | MP0003638_abnormal_response/metabolism_ | 0.46314830 |
| 76 | MP0005058_abnormal_lysosome_morphology | 0.44830522 |
| 77 | MP0002136_abnormal_kidney_physiology | 0.44703342 |
| 78 | MP0008873_increased_physiological_sensi | 0.44630734 |
| 79 | MP0009785_altered_susceptibility_to | 0.42150981 |
| 80 | MP0002928_abnormal_bile_duct | 0.41024863 |
| 81 | MP0005248_abnormal_Harderian_gland | 0.40672851 |
| 82 | MP0003953_abnormal_hormone_level | 0.40385585 |
| 83 | MP0003724_increased_susceptibility_to | 0.39907286 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.39260945 |
| 85 | MP0003075_altered_response_to | 0.39165172 |
| 86 | MP0003436_decreased_susceptibility_to | 0.39096165 |
| 87 | MP0005166_decreased_susceptibility_to | 0.37259218 |
| 88 | MP0009672_abnormal_birth_weight | 0.36196514 |
| 89 | MP0004381_abnormal_hair_follicle | 0.34788472 |
| 90 | MP0005666_abnormal_adipose_tissue | 0.34695643 |
| 91 | MP0006082_CNS_inflammation | 0.34103326 |
| 92 | MP0000579_abnormal_nail_morphology | 0.33020672 |
| 93 | MP0009115_abnormal_fat_cell | 0.32675771 |
| 94 | MP0010386_abnormal_urinary_bladder | 0.32330084 |
| 95 | MP0000249_abnormal_blood_vessel | 0.31281456 |
| 96 | MP0002796_impaired_skin_barrier | 0.30577809 |
| 97 | MP0002168_other_aberrant_phenotype | 0.30220127 |
| 98 | MP0001243_abnormal_dermal_layer | 0.30212262 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.30193101 |
| 100 | MP0004883_abnormal_blood_vessel | 0.29967045 |
| 101 | MP0009384_cardiac_valve_regurgitation | 0.28145461 |
| 102 | MP0002970_abnormal_white_adipose | 0.28103595 |
| 103 | MP0000467_abnormal_esophagus_morphology | 0.28013029 |
| 104 | MP0001853_heart_inflammation | 0.27372005 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.26638699 |
| 106 | MP0000566_synostosis | 0.26527275 |
| 107 | MP0001881_abnormal_mammary_gland | 0.26508187 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.26076142 |
| 109 | MP0002132_abnormal_respiratory_system | 0.25944960 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.23774599 |
| 111 | MP0001851_eye_inflammation | 0.23480222 |
| 112 | MP0002090_abnormal_vision | 0.23419808 |
| 113 | MP0004272_abnormal_basement_membrane | 0.23411156 |
| 114 | MP0002060_abnormal_skin_morphology | 0.22612512 |
| 115 | MP0005164_abnormal_response_to | 0.22189516 |
| 116 | MP0005197_abnormal_uvea_morphology | 0.21973850 |
| 117 | MP0003959_abnormal_lean_body | 0.21239707 |
| 118 | MP0002128_abnormal_blood_circulation | 0.18390289 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.17664879 |
| 120 | MP0002295_abnormal_pulmonary_circulatio | 0.17611480 |
| 121 | MP0000920_abnormal_myelination | 0.16798853 |
| 122 | MP0001440_abnormal_grooming_behavior | 0.15420796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.49569698 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.48016195 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.32054441 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.71252712 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.64564626 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.63401261 |
| 7 | Xanthomatosis (HP:0000991) | 6.32389834 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.74161552 |
| 9 | Complement deficiency (HP:0004431) | 5.20164919 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.91551076 |
| 11 | Joint hemorrhage (HP:0005261) | 4.78672591 |
| 12 | Hyperammonemia (HP:0001987) | 4.60615685 |
| 13 | Epidermoid cyst (HP:0200040) | 4.51828838 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.49101160 |
| 15 | Hyperglycinemia (HP:0002154) | 4.44301980 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 4.39190965 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 4.25295842 |
| 18 | Abnormality of methionine metabolism (HP:0010901) | 4.25070632 |
| 19 | Ketosis (HP:0001946) | 4.24438052 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.21440218 |
| 21 | Fat malabsorption (HP:0002630) | 4.18574037 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.13888419 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.09772289 |
| 24 | Hyperglycinuria (HP:0003108) | 3.98619661 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94788452 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.94788452 |
| 27 | Nephritis (HP:0000123) | 3.85749077 |
| 28 | Conjugated hyperbilirubinemia (HP:0002908) | 3.85354489 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.84984767 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.83587828 |
| 31 | Abnormality of complement system (HP:0005339) | 3.79762695 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77448032 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.73968567 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.37503432 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.35991471 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.34385238 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.19427834 |
| 38 | Steatorrhea (HP:0002570) | 3.13780472 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.06677058 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06650052 |
| 41 | Reduced antithrombin III activity (HP:0001976) | 3.02663873 |
| 42 | Ketoacidosis (HP:0001993) | 2.98211158 |
| 43 | Myocardial infarction (HP:0001658) | 2.97753745 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.96043743 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.95363290 |
| 46 | Spontaneous abortion (HP:0005268) | 2.91839632 |
| 47 | Osteomalacia (HP:0002749) | 2.78985000 |
| 48 | Metabolic acidosis (HP:0001942) | 2.77423638 |
| 49 | Skin nodule (HP:0200036) | 2.76261430 |
| 50 | Abnormality of purine metabolism (HP:0004352) | 2.68181163 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.66281855 |
| 52 | Vascular calcification (HP:0004934) | 2.63862257 |
| 53 | Lethargy (HP:0001254) | 2.61736154 |
| 54 | Dicarboxylic aciduria (HP:0003215) | 2.60639830 |
| 55 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60639830 |
| 56 | Acanthocytosis (HP:0001927) | 2.57693405 |
| 57 | Fair hair (HP:0002286) | 2.47496209 |
| 58 | Purpura (HP:0000979) | 2.47367931 |
| 59 | Pulmonary embolism (HP:0002204) | 2.46835165 |
| 60 | Spastic diplegia (HP:0001264) | 2.45508447 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.44724405 |
| 62 | Neonatal hypoglycemia (HP:0001998) | 2.44366044 |
| 63 | Abnormal gallbladder morphology (HP:0012437) | 2.44000783 |
| 64 | Glomerulonephritis (HP:0000099) | 2.41827962 |
| 65 | Mitral stenosis (HP:0001718) | 2.41240162 |
| 66 | Cerebral edema (HP:0002181) | 2.39269797 |
| 67 | Gout (HP:0001997) | 2.39136363 |
| 68 | Cholelithiasis (HP:0001081) | 2.38721225 |
| 69 | Irritability (HP:0000737) | 2.35245862 |
| 70 | Malnutrition (HP:0004395) | 2.34309533 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.33657497 |
| 72 | Neonatal onset (HP:0003623) | 2.28898701 |
| 73 | Abnormal gallbladder physiology (HP:0012438) | 2.24378570 |
| 74 | Cholecystitis (HP:0001082) | 2.24378570 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.21836264 |
| 76 | Esophageal varix (HP:0002040) | 2.21616942 |
| 77 | Amyloidosis (HP:0011034) | 2.17847201 |
| 78 | Pancreatitis (HP:0001733) | 2.15992236 |
| 79 | Gingival bleeding (HP:0000225) | 2.13937516 |
| 80 | Menorrhagia (HP:0000132) | 2.13696443 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.13682117 |
| 82 | Brushfield spots (HP:0001088) | 2.13087453 |
| 83 | Elevated alkaline phosphatase (HP:0003155) | 2.10579547 |
| 84 | Poikilocytosis (HP:0004447) | 2.09656566 |
| 85 | Late onset (HP:0003584) | 2.08826196 |
| 86 | Vomiting (HP:0002013) | 2.06066051 |
| 87 | Thrombophlebitis (HP:0004418) | 2.05700861 |
| 88 | Generalized aminoaciduria (HP:0002909) | 2.05143742 |
| 89 | Hyperphosphaturia (HP:0003109) | 2.04969187 |
| 90 | Opisthotonus (HP:0002179) | 2.03656692 |
| 91 | Enlarged kidneys (HP:0000105) | 2.03016745 |
| 92 | Hemorrhage of the eye (HP:0011885) | 2.00600392 |
| 93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97183535 |
| 94 | Rickets (HP:0002748) | 1.96958636 |
| 95 | Abnormality of the gallbladder (HP:0005264) | 1.95897191 |
| 96 | Abnormality of the Achilles tendon (HP:0005109) | 1.92784560 |
| 97 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.91101382 |
| 98 | Hypophosphatemic rickets (HP:0004912) | 1.90812181 |
| 99 | Arthropathy (HP:0003040) | 1.90263352 |
| 100 | Hydroxyprolinuria (HP:0003080) | 1.90184091 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 1.90184091 |
| 102 | Glycosuria (HP:0003076) | 1.88912859 |
| 103 | Abnormality of urine glucose concentration (HP:0011016) | 1.88912859 |
| 104 | Increased serum ferritin (HP:0003281) | 1.88333000 |
| 105 | Abnormality of iron homeostasis (HP:0011031) | 1.86661531 |
| 106 | Renal cortical cysts (HP:0000803) | 1.86276693 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.85893030 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85726620 |
| 109 | Abnormal biliary tract physiology (HP:0012439) | 1.82856343 |
| 110 | Bile duct proliferation (HP:0001408) | 1.82856343 |
| 111 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80702426 |
| 112 | Gangrene (HP:0100758) | 1.80543180 |
| 113 | Elevated hepatic transaminases (HP:0002910) | 1.79999704 |
| 114 | Abnormality of vitamin metabolism (HP:0100508) | 1.79965199 |
| 115 | Status epilepticus (HP:0002133) | 1.79303310 |
| 116 | Hyperglycemia (HP:0003074) | 1.77850338 |
| 117 | Atrioventricular block (HP:0001678) | 1.77820527 |
| 118 | Reticulocytosis (HP:0001923) | 1.76772837 |
| 119 | Alkalosis (HP:0001948) | 1.76126914 |
| 120 | Joint swelling (HP:0001386) | 1.75077983 |
| 121 | Generalized hypopigmentation of hair (HP:0011358) | 1.72288045 |
| 122 | Cerebral palsy (HP:0100021) | 1.68469739 |
| 123 | Bifid scrotum (HP:0000048) | 1.66277955 |
| 124 | Epistaxis (HP:0000421) | 1.64057777 |
| 125 | Abnormal urine phosphate concentration (HP:0012599) | 1.62581626 |
| 126 | Increased mean platelet volume (HP:0011877) | 1.58817183 |
| 127 | Increased serum pyruvate (HP:0003542) | 1.53539871 |
| 128 | Abnormal delivery (HP:0001787) | 1.49165851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.22723837 |
| 2 | FGFR4 | 4.73332182 |
| 3 | SIK1 | 4.68868277 |
| 4 | ERN1 | 4.15813369 |
| 5 | TAOK3 | 3.05225319 |
| 6 | INSRR | 3.02103636 |
| 7 | ERBB4 | 2.74334126 |
| 8 | PIK3CA | 2.41508084 |
| 9 | MAP2K4 | 2.31771660 |
| 10 | MST1R | 2.18614247 |
| 11 | PKN2 | 2.14023484 |
| 12 | MYLK | 2.06317675 |
| 13 | PRPF4B | 1.86389529 |
| 14 | PIK3CG | 1.85799079 |
| 15 | FLT3 | 1.84212391 |
| 16 | MAPK11 | 1.78873027 |
| 17 | TYK2 | 1.78241350 |
| 18 | PDK2 | 1.76582370 |
| 19 | FRK | 1.67983226 |
| 20 | NTRK3 | 1.67160603 |
| 21 | TRIB3 | 1.66661625 |
| 22 | LATS1 | 1.65719450 |
| 23 | DAPK2 | 1.50416369 |
| 24 | ABL2 | 1.50194111 |
| 25 | PTK6 | 1.48871510 |
| 26 | FGFR2 | 1.41763888 |
| 27 | NEK9 | 1.38280509 |
| 28 | NLK | 1.36846288 |
| 29 | KDR | 1.33761119 |
| 30 | PINK1 | 1.23180833 |
| 31 | TNK2 | 1.21600101 |
| 32 | ARAF | 1.21173828 |
| 33 | JAK2 | 1.20950333 |
| 34 | MUSK | 1.19918092 |
| 35 | MAP3K7 | 1.16140178 |
| 36 | GRK6 | 1.14208161 |
| 37 | PRKAA2 | 1.11219290 |
| 38 | PRKG1 | 1.08454345 |
| 39 | MAP2K3 | 1.07613933 |
| 40 | TBK1 | 1.06451456 |
| 41 | STK16 | 1.05291544 |
| 42 | JAK1 | 1.02224258 |
| 43 | MAP3K14 | 1.01960543 |
| 44 | ERBB2 | 0.99606573 |
| 45 | MAPK4 | 0.99083180 |
| 46 | SCYL2 | 0.98698214 |
| 47 | PRKCZ | 0.96400766 |
| 48 | MAP3K3 | 0.94440103 |
| 49 | PRKACA | 0.94355056 |
| 50 | STK38L | 0.93474237 |
| 51 | CSNK1D | 0.93011742 |
| 52 | MAP3K10 | 0.91096259 |
| 53 | FER | 0.87974922 |
| 54 | EPHB1 | 0.86561012 |
| 55 | EPHA3 | 0.85781384 |
| 56 | WNK3 | 0.85255593 |
| 57 | MET | 0.84038326 |
| 58 | CDK6 | 0.83518527 |
| 59 | IRAK3 | 0.82986691 |
| 60 | MAP3K11 | 0.82378487 |
| 61 | MAPK15 | 0.79723324 |
| 62 | MAP3K12 | 0.77481367 |
| 63 | CAMKK1 | 0.76959546 |
| 64 | MAPK12 | 0.76871084 |
| 65 | MAP2K6 | 0.76362143 |
| 66 | TIE1 | 0.75595951 |
| 67 | CAMKK2 | 0.74917128 |
| 68 | RIPK1 | 0.73990534 |
| 69 | PRKACG | 0.73867989 |
| 70 | CAMK2G | 0.73034975 |
| 71 | CSK | 0.71580181 |
| 72 | DYRK1B | 0.70126761 |
| 73 | PRKCB | 0.67636112 |
| 74 | GSK3A | 0.66793659 |
| 75 | PRKACB | 0.66479968 |
| 76 | PRKAA1 | 0.65343165 |
| 77 | CAMK1D | 0.63699819 |
| 78 | SGK3 | 0.63075692 |
| 79 | RPS6KA3 | 0.62969374 |
| 80 | TAOK2 | 0.62942079 |
| 81 | MAP3K2 | 0.62357307 |
| 82 | EIF2AK1 | 0.62101738 |
| 83 | MAPK7 | 0.61392122 |
| 84 | SGK1 | 0.60874068 |
| 85 | IKBKE | 0.56403565 |
| 86 | PTK2 | 0.54521843 |
| 87 | GRK1 | 0.54355520 |
| 88 | FGFR3 | 0.54340138 |
| 89 | STK38 | 0.54167299 |
| 90 | CSNK2A1 | 0.53529064 |
| 91 | CSF1R | 0.53233343 |
| 92 | EPHA4 | 0.52248529 |
| 93 | CSNK1E | 0.52079514 |
| 94 | PRKCQ | 0.51713832 |
| 95 | PDPK1 | 0.50990474 |
| 96 | ZAP70 | 0.50190157 |
| 97 | TGFBR2 | 0.49481882 |
| 98 | MAP3K5 | 0.48198182 |
| 99 | CSNK1G1 | 0.47190811 |
| 100 | BRSK2 | 0.47011448 |
| 101 | CSNK2A2 | 0.46804153 |
| 102 | CSNK1A1 | 0.46714112 |
| 103 | SGK2 | 0.45503126 |
| 104 | PRKCG | 0.44724321 |
| 105 | IGF1R | 0.44634478 |
| 106 | CDK4 | 0.44363733 |
| 107 | MAPKAPK3 | 0.43110259 |
| 108 | EPHA2 | 0.42534836 |
| 109 | AKT3 | 0.41100685 |
| 110 | MAP2K1 | 0.40839364 |
| 111 | SRC | 0.39148040 |
| 112 | RET | 0.37613981 |
| 113 | EIF2AK3 | 0.36236878 |
| 114 | PBK | 0.35610205 |
| 115 | NEK1 | 0.33675752 |
| 116 | ICK | 0.33075691 |
| 117 | IRAK1 | 0.32670501 |
| 118 | CAMK4 | 0.32241248 |
| 119 | MTOR | 0.31940888 |
| 120 | MAP3K13 | 0.30887171 |
| 121 | AKT2 | 0.29942879 |
| 122 | SGK494 | 0.29803477 |
| 123 | SGK223 | 0.29803477 |
| 124 | PDK1 | 0.29522397 |
| 125 | EGFR | 0.29279671 |
| 126 | PKN1 | 0.29185993 |
| 127 | IRAK2 | 0.28830697 |
| 128 | PRKCA | 0.28152900 |
| 129 | MAP3K6 | 0.28059638 |
| 130 | LATS2 | 0.27630898 |
| 131 | MAP2K2 | 0.26159622 |
| 132 | CSNK1G2 | 0.26028931 |
| 133 | PDK4 | 0.24301434 |
| 134 | PDK3 | 0.24301434 |
| 135 | CSNK1G3 | 0.22294332 |
| 136 | MAP3K1 | 0.21315551 |
| 137 | ABL1 | 0.20723195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.44729956 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56813886 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44550008 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30194931 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.01169786 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72629126 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.69591964 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68345611 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59791591 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49359187 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47126949 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36216912 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.34184659 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.25437539 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14283811 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.06407337 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.06082161 |
| 18 | Peroxisome_Homo sapiens_hsa04146 | 2.05073343 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.02868944 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94277961 |
| 21 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.92639510 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88679894 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84951151 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.84838718 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77062390 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73636470 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71913416 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71476683 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.70051408 |
| 30 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.67166101 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61923701 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56540006 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56192422 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.52387526 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.48773854 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47701318 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43239336 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34561393 |
| 39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32058172 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31790584 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30462608 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28337944 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24070814 |
| 44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.23214415 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.22256252 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16144874 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12061122 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09513983 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01332092 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99108785 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98135479 |
| 52 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97996819 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.97208097 |
| 54 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97173287 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93752722 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90514034 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87669160 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84238779 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.79602876 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74417557 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67961588 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67788577 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67783186 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56724333 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49107361 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45964436 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.45451862 |
| 68 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45273227 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.36836650 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.32205376 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29704399 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29566890 |
| 73 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25368372 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24017888 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.22219280 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20056215 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16943315 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16883188 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.07154575 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.01292321 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00306516 |
| 82 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2536911 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | -0.2493515 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2467512 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2423043 |
| 86 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2393804 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2328127 |
| 88 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2261229 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2231036 |
| 90 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.2157850 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2107132 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1997449 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1995466 |
| 94 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1962015 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1796286 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1767957 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1696281 |
| 98 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1673220 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1372270 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1352674 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1330891 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1172139 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1077491 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1074271 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | -0.0589613 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0524718 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0506908 |
| 108 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0506321 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0473521 |

